Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8+ T Cell Epitopes-Reference-Cited by-同舟云学术

Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8+ T Cell Epitopes

Published:2014-07-22 Issue:3 Volume:2 Page:581-600
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Becker Pablo,Nörder Miriam,Weissmann Sebastian,Ljapoci Ronny,Erfle Volker,Drexler Ingo,Guzmán Carlos

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Link

http://www.mdpi.com/2076-393X/2/3/581/pdf

Reference57 articles.

1. Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line

2. Highly attenuated modified vaccinia virus ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells;Drexler;J. Gen. Virol.,1998

3. Nonreplicating vaccinia vector efficiently expresses recombinant genes.

4. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine;Blanchard;J. Gen. Virol.,1998

5. The Block in Assembly of Modified Vaccinia Virus Ankara in HeLa Cells Reveals New Insights into Vaccinia Virus Morphogenesis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector;Frontiers in Immunology;2024-09-12

2. Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice;Vaccines;2024-08-22

3. Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice;Pathogens;2023-06-23

4. Preclinical evaluation of a recombinant MVA expressing the hemagglutinin-neuraminidase envelope protein of parainfluenza virus 5 (Mammalian orthorubulavirus 5);Veterinary Vaccine;2023-06

5. Identification and evaluation of a panel of strong constitutive promoters in Listeria monocytogenes for improving the expression of foreign antigens;Applied Microbiology and Biotechnology;2021-06